Monoclonal Antibodies Core Unit

Home | Research & Innovation | Scientific Programmes | Biotechnology Programme | Monoclonal Antibodies Core Unit

Technicians

  • Álvaro García
  • Scherezade Jiménez
  • Lorena Maestre
  • Ana Isabel Reyes
  • Andrea Belén Romero

One of the greatest advances of the last decades in the field of biotechnology has been the development of hybridoma technology to generate monoclonal antibodies (mAbs). MAbs have revolutionised the field of research and medicine. Antibodies are essential tools in a broad array of laboratory techniques and procedures, and they are used to address basic research questions, leading to a better understanding of life processes. Their outstanding specificity makes them exquisite tools that enable researchers to explore and dissect biological processes in detail; they are particularly helpful in the investigation of new approaches for the diagnosis, prevention, and treatment of cancer.

The Monoclonal Antibodies Unit provides CNIO Research Groups with an à la carte generation of mAbs using hybridoma technology. We are highly specialised in the production of mouse and rat monoclonal antibodies. The Unit also offers mAb characterisation and validation, medium-scale mAb production, as well as a Mycoplasma testing service for the cell culture facility.

Publications

Up